As far as the imaging of T lymphocytes in the tumour environment is concerned, both iodinated and techenetiated IL2 have been used for imaging of squamous cell carcinoma of the head and neck [111], renal cell carcinoma [112] and in melanoma [110]. This evidence concerns the gene IL2 and hereditary clear cell renal cell carcinoma.